S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
S&P 500   4,960.48 (-1.01%)
DOW   37,914.86 (+0.37%)
QQQ   414.27 (-2.16%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
NYSE:BAK

Braskem (BAK) Stock Price, News & Analysis

$8.66
+0.02 (+0.23%)
(As of 02:58 PM ET)
Today's Range
$8.51
$8.75
50-Day Range
$6.85
$10.91
52-Week Range
$6.30
$12.67
Volume
493,445 shs
Average Volume
1.01 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.50

Braskem MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
193.1% Upside
$25.50 Price Target
Short Interest
Healthy
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.99) to $0.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.98 out of 5 stars

BAK stock logo

About Braskem Stock (NYSE:BAK)

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins. This segment also produces and sells polyethylene (PE) and polypropylene (PP); supplies electricity and other inputs to second-generation producers; produces and sells of PE, including the production of green PE from renewable resources; and produces and sells polyvinyl chloride and caustic soda. The United States and Europe segment produces and sells PP in the United States and Germany. The Mexico segment produces and sells ethylene, high-density PE, and low-density PE in Mexico. It also manufactures, sells, imports, and exports chemicals, petrochemicals, and fules; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in Camaçari, Brazil.

BAK Stock Price History

BAK Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Braskem S.A. (BAK) Q4 2023 Earnings Call Transcript
BAK Stock Earnings: Braskem Misses EPS for Q4 2023
Recap: Braskem Q4 Earnings
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Braskem SA ADR BAK
Adnoc Makes New Offer to Buy Controlling Stake in Braskem
See More Headlines
Receive BAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Braskem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/19/2024
Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
N/A
Employees
8,668
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.50
High Stock Price Target
$40.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+195.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-917,240,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.14 billion
Cash Flow
$0.28 per share
Book Value
$2.62 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.96
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Roberto Bischoff (Age 68)
    Chief Executive Officer
  • Mr. Pedro van Langendonck Teixeira de Freitas (Age 49)
    CFO and Head of Procurement & Institutional Relation
  • Mr. Daniel Sales Correa (Age 55)
    Executive Officer and Head of Investments & Digital Technologies
  • Mr. Everson Bassinello
    Chief Compliance Officer
  • Ms. Cristiana Lapa (Age 47)
    General Counsel & Corporate Governance Officer
  • Mr. Marcelo Arantes De Carvalho (Age 56)
    Executive Officer and Head of People, Communication, Marketing & Sustainable Development
  • Mr. Marcelo de Oliveira Cerqueira (Age 59)
    Executive Officer and Head of Brazil Manufacturing & Global Industrial Operations
  • Mr. Edison Terra Filho (Age 52)
    Executive Officer and Head of the Olefins & Polyolefins South America
  • Dr. Daniel P. MacEachran
    Head of Metabolic Engineering
  • Mr. Flávio Rossini
    Company Secretary

BAK Stock Analysis - Frequently Asked Questions

Should I buy or sell Braskem stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAK, but not buy additional shares or sell existing shares.
View BAK analyst ratings
or view top-rated stocks.

What is Braskem's stock price target for 2024?

5 brokers have issued 12-month price objectives for Braskem's shares. Their BAK share price targets range from $11.00 to $40.00. On average, they expect the company's stock price to reach $25.50 in the next twelve months. This suggests a possible upside of 193.1% from the stock's current price.
View analysts price targets for BAK
or view top-rated stocks among Wall Street analysts.

How have BAK shares performed in 2024?

Braskem's stock was trading at $8.82 at the beginning of the year. Since then, BAK stock has decreased by 1.4% and is now trading at $8.70.
View the best growth stocks for 2024 here
.

Are investors shorting Braskem?

Braskem saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 2,030,000 shares, a decrease of 11.4% from the February 29th total of 2,290,000 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is currently 1.9 days.
View Braskem's Short Interest
.

When is Braskem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our BAK earnings forecast
.

How were Braskem's earnings last quarter?

Braskem S.A. (NYSE:BAK) issued its quarterly earnings data on Tuesday, March, 19th. The company reported ($0.80) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by $0.25. The business earned $3.37 billion during the quarter, compared to analyst estimates of $3.50 billion. Braskem had a negative trailing twelve-month return on equity of 77.04% and a negative net margin of 6.61%.

What is Roberto Lopes Pontes Simões' approval rating as Braskem's CEO?

31 employees have rated Braskem Chief Executive Officer Roberto Lopes Pontes Simões on Glassdoor.com. Roberto Lopes Pontes Simões has an approval rating of 100% among the company's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Braskem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Enterprise Products Partners (EPD), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro Biotech (ADRO), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP) and Chevron (CVX).

How do I buy shares of Braskem?

Shares of BAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BAK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners